New Genomic Somatic Amplifications and Deletions in Papillary Thyroid Cancer
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
McLeod D, Sawka A, Cooper D
. Controversies in primary treatment of low-risk papillary thyroid cancer. Lancet. 2013; 381(9871):1046-57.
DOI: 10.1016/S0140-6736(12)62205-3.
View
2.
Griffith O, Melck A, Jones S, Wiseman S
. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J Clin Oncol. 2006; 24(31):5043-51.
DOI: 10.1200/JCO.2006.06.7330.
View
3.
Ahn H, Kim H, Welch H
. Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. N Engl J Med. 2014; 371(19):1765-7.
DOI: 10.1056/NEJMp1409841.
View
4.
Huang M, Weiss W
. Neuroblastoma and MYCN. Cold Spring Harb Perspect Med. 2013; 3(10):a014415.
PMC: 3784814.
DOI: 10.1101/cshperspect.a014415.
View
5.
. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014; 159(3):676-90.
PMC: 4243044.
DOI: 10.1016/j.cell.2014.09.050.
View